Opposite associations of circulating aldosterone and atrial natriuretic peptide with left ventricular diastolic function in essential hypertension

Journal of Human Hypertension

Volumn 12, Issue 3, 1998, Pages 195-202

  Fagard, R H ^a,b   Lijnen, P J ^a   Petrov, V V ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Aldosterone; Angiotensin; Atrial natriuretic peptide; Echocardiography; Left ventricular function; Left ventricular hypertrophy; Renin

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; RENIN;

ADULT; AGE; ARTICLE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; GENDER; HEART ATRIUM CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MITOGENESIS; PLASMA RENIN ACTIVITY; STRUCTURE ACTIVITY RELATION; WORLD HEALTH ORGANIZATION;

EID: 0031886048     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000590     Document Type: Article

References (48)

1. Morgan HE, Barker KM, Cardiac hypertrophy. Mechanical, neural and endocrine dependence. Circulation 1991; 83: 13-25.
2. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy. J Hypertens 1991; 9: 3-15.
3. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-1865.
4. Weber KT, Sun Y, Guarda E. Nonclassic actions of angiotensin II and aldosterone in nonclassic target tissue (the heart): Relevance to hypertensive heart disease. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management, 2nd Edition. Raven Press Ltd: New York, USA, 1995, pp 2203-2223.
5. Lewicki JA, Protter AA. Physiological studies of the natriuretic peptide family. In: Laragh JH, Brenner BM (eds). Hypertension: Pathophysiology, Diagnosis and Management, 2nd Edition. Raven Press Ltd: New York, USA, 1995, pp 1029-1053.
6. Brilla CG et al. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990; 67: 1355-1364.
7. Brilla CG, Weber KT. Reactive and separative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992; 26: 671-677.
8. Robert V et al. Increased cardiac types I and II Collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994; 24: 30-36.
9. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, Hypertension and Cardiac Fibrosis. J Clin Invest 1994; 93: 2578-2583.
10. Brilla CG, Zhou G, Weber K, Matsubara L. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26: 809-820.
11. Fullerton MJ, Funder JW. Aldosterone and cardiac fibrosis: in vitro studies. Cardiovasc Res 1994; 28: 1863-1867.
12. Fujisaki H et al. Natriuretic peptides inhibit angiotensin II-induced proliferation of rat cardiac fibroblasts by blocking endothelin-1 gene expression. J Clin Invest 1995; 96: 1059-1065.
13. Devereux RB, Savage DD, Drayer JIM, Laragh JH. Left ventricular hypertrophy and function in high, normal, and low-renin forms of essential hypertension. Hypertension 1982; 4: 524-531.
14. Rowlands DB et al. Assessment of left ventricular mass and its response to antihypertensive treatment. Lancet 1982; 1: 467-470.
15. Hartford M et al. Left ventricular mass in middle-aged men: Relationship to blood pressure, sympathetic nervous activity, hormonal and metabolic factors. Clin Exp Hyper- Theory and Practice 1983; A5: 1429-1451.
16. Hammond IW, et al. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986; 7: 639-650.
17. Schmieder RE et al. Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension? Am J Med 1988; 84 (Suppl 3A): 136-139.
18. Daniels SD, Meyer RA, Loggie JMH. Determinants of cardiac involvement in children and adolescents with essential hypertension. Circulation 1990; 82: 1243-1248.
19. Bauwens FR et al. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1991; 68: 925-929.
20. Harrap SB et al. Plasma angiotensin II, predisposition to hypertension and left ventricular size in healthy young adults. Circulation 1996; 93: 1148-1154.
21. Yoshitomi Y et al. Comparison of changes in cardiac structure after treatment in secondary hypertension. Hypertension 1996; 27 (Part 1): 319-323.
22. Schroeder AP et al. Influence of humoral and neuro-hormonal factors on cardiovascular hypertrophy in untreated essential hypertensives. Am J Hypertens 1996; 9: 207-215.
23. Rossi GP et al. Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996; 27: 1039-1045.
24. Ganau A et al. Plasma atrial natriuretic factor in essential hypertension: relation to cardiac size, function and systemic hemodynamics. J Am Coll Cardiol 1989; 14: 715-724.
25. Dessì-Fulgheri P et al. High levels of plasma atrial natriuretic factor and impaired left ventricular diastolic function in hypertensives without left ventricular hypertrophy. J Hypertens 1992; 10: 161-165.
26. Lang CC et al. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 1994; 127: 1635-1636.
27. Kohno M et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995; 98: 257-265.
28. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
29. Fagard RH, Reversibility of left ventricular hypertrophy by antihypertensive drugs. Neth J Med 1995; 47: 173-179.
30. Harizi RC, Bianco JA, Alpert JS. Diastolic function of the heart in clinical cardiology. Arch Int Med 1988; 148: 99-109.
31. Sugihara N et al. Diastolic dysfunction and its relation to myocardial fibrosis in essential hypertension. J Cardiol 1988; 18: 353-361.
32. Guidelines Subcommittee. 1993 Guidelines for the Management of Mild Hypertension: Memorandum from a WHO/ISH meeting. J Hypertens 1993; 11: 305-918.
33. Bielen E, Fagard R, Amery A. The inheritance of left ventricular structure and function assessed by imaging and Doppler echocardiography. Am Heart J 1991; 121: 1743-1749.
34. Sahn DJ, De Maria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurement. Circulation 1978; 58: 1072-1083.
35. Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
36. Fagard R, Bielen E, Lijnen P, Amery A. Cardiac variables and blood pressure as determinants of left ventricular inflow velocities. J Hum Hypertens 1993; 7: 7-12.
37. Fyhrquist F, Puutula L. Faster radioimmunoassay of angiotensin I at 37°C. Clin Chem 1978; 24: 115-118.
38. Lijnen P, Amery A, Fagard R, Katz F. Radioimmunoassay of angiotensin II in unextracted plasma, Clin Chim Acta 1978; 88: 403-412.
39. Lijnen P, Amery A, Fagard R, Corvol P. Direct radioimmunoassay of plasma aldosterone in normal subjects. Clin Chim Acta 1978; 84: 305-314.
40. Lijnen P et al. Plasma atrial natriuretic peptide and cyclic nucleotide levels before and after a marathon. J Appl Physiol 1987; 63: 1180-1184.
41. Bauersfeld W, Ratge D, Knoll E, Wisser H. Bestimmung der Catecholamine in Plasma mit HPLC und amperometrischer Detektion. Fresenius Z Anal Chem 1984; 317: 679-680.
42. Rinaldi JP, Diebold B. Normal intracardiac Doppler flows. In: Roelandt JRTC, Sutherland GR, Iliceto S, Linker DT (eds). Cardiac Ultrasound. Churchill Livingstone: Edinburgh, 1993, pp 141-153.
43. Fagard R. Impact of different sports and training on cardiac structure and function. Cardiol Clin 1992; 10: 241-256.
44. Manolio TA et al. Relation of alcohol intake to left ventricular mass: The Framingham Study. J Am Coll Cardiol 1991; 17: 717-721.
45. Liebson PR et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993; 87: 476-486.
46. Doering CW et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988; 22: 686-695.
47. Lombès M et al. Prerequisite for cardiac aldosterone action. Mineralocorticoid receptor and 11 β-HSD in the human heart. Circulation 1995; 92: 175-182.
48. Lin X et al. Gene expression of natriuretic peptide receptors in myocardial cells. Circ Res 1995; 77: 750-758.